208 related articles for article (PubMed ID: 38485992)
1. Deprescribing potential of commonly used medications among community-dwelling older adults: insights from a pharmacist's geriatric assessment.
Bužančić I; Držaić M; Kummer I; Ortner Hadžiabdić M; Brkić J; Fialová D
Sci Rep; 2024 Mar; 14(1):6235. PubMed ID: 38485992
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
[TBL] [Abstract][Full Text] [Related]
3. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
Leszcynski L; Bente J
Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
[No Abstract] [Full Text] [Related]
4. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
5. Deprescribing in a multimorbid older adult: A case vignette study among community pharmacists and primary care physicians.
Bužančić I; Ortner Hadžiabdić M
Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):729-740. PubMed ID: 37177977
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Pharmacist-Managed Nonsteroidal Anti-Inflammatory Drugs Deprescribing Program in an Integrated Health Care System.
Rashid R; Chang C; Niu F; Deguzman L; Draves M; Awsare S; Hui R
J Manag Care Spec Pharm; 2020 Jul; 26(7):918-924. PubMed ID: 32584681
[TBL] [Abstract][Full Text] [Related]
7. Continue or not to continue? Attitudes towards deprescribing among community-dwelling older adults in China.
Tan J; Wang M; Pei X; Sun Q; Lu C; Wang Y; Zhang L; Wu C
BMC Geriatr; 2022 Jun; 22(1):492. PubMed ID: 35676628
[TBL] [Abstract][Full Text] [Related]
8. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Pharmacist-Led Deprescribing of NSAIDs in Community-Dwelling Older Adults.
Sanyal C; Turner JP; Martin P; Tannenbaum C
J Am Geriatr Soc; 2020 May; 68(5):1090-1097. PubMed ID: 32105355
[TBL] [Abstract][Full Text] [Related]
11. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
[TBL] [Abstract][Full Text] [Related]
12. Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis.
Kassis A; Moles R; Carter S
Res Social Adm Pharm; 2024 Aug; 20(8):697-712. PubMed ID: 38685144
[TBL] [Abstract][Full Text] [Related]
13. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
[TBL] [Abstract][Full Text] [Related]
14. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
15. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
[TBL] [Abstract][Full Text] [Related]
16. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
[TBL] [Abstract][Full Text] [Related]
17. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
Anderson K; Freeman C; Foster M; Scott I
J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
[TBL] [Abstract][Full Text] [Related]
18. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing deprescribing habits among geriatricians.
Ní Chróinín D; Ní Chróinín C; Beveridge A
Age Ageing; 2015 Jul; 44(4):704-8. PubMed ID: 25758409
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
